Verastem reported $-16950000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Abbvie ABBV:US $ 7127M 482M
AstraZeneca AZN:LN 4187M 687M
Curis CRIS:US $ -15.1M 2.57M
Cytokinetics CYTK:US $ -76.52M 58.35M
Epizyme EPZM:US $ -49.63M 0.33M
Gilead Sciences GILD:US $ 3422M 1947M
Immunogen IMGN:US $ -22.38M 11.71M
Laboratory Of America LH:US $ 863.2M 81.1M
Novartis NOVN:VX SF 4552M 346M
Pfizer PFE:US $ 11182M 4046M
Tg Therapeutics TGTX:US $ -66.8M 26.07M
Verastem VSTM:US $ -16.95M 0.47M
YTE INCY:US $ 144.1M 9.29M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M